Stereotaxis (STXS) Total Current Liabilities (2010 - 2026)
Stereotaxis' (STXS) quarterly Total Current Liabilities came in at $23.1 million in Q1 2026, down 4.72% year-over-year from $24.2 million in Q1 2025, and up 3.25% quarter-over-quarter from $22.4 million in Q4 2025.
Analysis
Stereotaxis (STXS) Total Current Liabilities (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Total Current Liabilities for 17 consecutive years, with $23.1 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Total Current Liabilities fell 4.72% year-over-year to $23.1 million in Q1 2026; TTM through Mar 2026 was $23.1 million, a 4.72% decrease from a year earlier, with the FY2025 full-year figure at $22.4 million, up 3.51% from the prior year.
- Total Current Liabilities was $23.1 million for Q1 2026 at Stereotaxis, up from $22.4 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $24.2 million in Q1 2025 and troughed at $11.5 million in Q1 2022.
- A 5-year average of $16.9 million and a median of $14.4 million in 2023 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities slumped 31.14% in 2022 and soared 88.52% in 2025, its largest moves.
- Over 5 years, Total Current Liabilities stood at $14.3 million in 2022, then retreated by 7.31% to $13.2 million in 2023, then soared by 63.07% to $21.6 million in 2024, then gained by 3.51% to $22.4 million in 2025, then grew by 3.25% to $23.1 million in 2026.
- The last three Total Current Liabilities figures came in at $23.1 million (Q1 2026), $22.4 million (Q4 2025), and $20.4 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 11.80 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 6.68 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 6.43 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 1.51 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 3.17 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.36 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | 23.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 23.09 Mn |
| Dec 31, 2025 | 22.36 Mn |
| Sep 30, 2025 | 20.37 Mn |
| Jun 30, 2025 | 20.75 Mn |
| Mar 31, 2025 | 24.23 Mn |
| Dec 31, 2024 | 21.60 Mn |
| Sep 30, 2024 | 20.72 Mn |
| Jun 30, 2024 | 12.25 Mn |
| Mar 31, 2024 | 12.85 Mn |
| Dec 31, 2023 | 13.25 Mn |
| Sep 30, 2023 | 13.03 Mn |
| Jun 30, 2023 | 14.38 Mn |
| Mar 31, 2023 | 14.27 Mn |
| Dec 31, 2022 | 14.29 Mn |
| Sep 30, 2022 | 15.55 Mn |
| Jun 30, 2022 | 13.66 Mn |
| Mar 31, 2022 | 11.49 Mn |
| Dec 31, 2021 | 13.26 Mn |
| Sep 30, 2021 | 13.84 Mn |
| Jun 30, 2021 | 13.44 Mn |